Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
Tags:
painkillers, Acadia, Eli Lilly, Ampio Pharmaceuticals, Aptinyx, Eliem Therapeutics, Vertanical, Teva Pharamceutical, Regeneron, Vivozon, Vertex Pharmaceuticals, Biogen
How Eli Lilly Is Thinning Out the Competition
Motley Fool
Wed, 08/17/22 - 11:46 am
Tags:
Eli Lilly, Mounjaro, diabetes
Eli Lilly says Indiana's abortion ban will force it to hire more outside the state
Fierce Pharma
Mon, 08/8/22 - 10:08 am
Tags:
Eli Lilly, Indiana, abortion, Supreme Court
Lilly takes long view on Alzheimer’s drug hopeful as FDA starts expedited review
BioPharma Dive
Fri, 08/5/22 - 10:59 am
Tags:
Eli Lilly, Alzheimer's disease, FDA, donanemab
Eli Lilly CEO Ricks echoes a growing refrain on price negotiations: 'We’ll focus our resources on other areas'
Endpoints
Fri, 08/5/22 - 10:47 am
Tags:
Eli Lilly, earnings, Pharma CEOs, Dave Ricks, drug pricing
Eli Lilly ordered to pay $61M over false rebate calculations
Beckers Hospital Review
Thu, 08/4/22 - 06:25 pm
Tags:
Eli Lilly, Illinois, Medicaid, legal
Despite drug launch streak, Lilly posts rare sales decline as Alimta succumbs to generics
Fierce Pharma
Thu, 08/4/22 - 12:01 pm
Tags:
Eli Lilly, earnings, Alimta
Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts
Fierce Pharma
Mon, 08/1/22 - 10:53 am
Tags:
Eli Lilly, AstraZeneca, JNJ, AbbVie, legislation, drug pricing, Medicare
A year after netting Takeda partnership, small molecule startup arms itself with some new cash
Endpoints
Wed, 07/27/22 - 10:52 am
Tags:
startups, BridGene Biosciences, Takeda, funding, Eli Lilly
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Tags:
Alzheimer's disease, Roche, Biogen, Eli Lilly, lecanemab, gantenerumab, Aduhelm
Innovent & Eli Lilly's Type 2 Diabetes Drug Lowers HbA1c, Scores Early Win
BioSpace
Tue, 07/19/22 - 10:26 am
Tags:
Innovent, Eli Lilly, type 2 diabetes, diabetes, mazdutide, clinical trials
Lilly taps Triastek to use 3D printing for gut-targeted drug delivery
Fierce Pharma
Mon, 07/18/22 - 09:55 am
Tags:
Eli Lilly, 3D printing, drug delivery, Triastek
Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts
Fierce Pharma
Sun, 07/17/22 - 11:07 pm
Tags:
Eli Lilly, Novo Nordisk, obesity
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
Tags:
FDA, drug approvals, Amicus, Bluebird Bio, Bristol Myers Squibb, Eli Lilly, Marinus Pharma, Amylyx, Novartis
Chasing AnaptysBio and Lilly, MiroBio rounds up $97M for autoimmune checkpoint agonist clinical trials
Fierce Biotech
Wed, 06/29/22 - 10:51 am
Tags:
MiroBio, venture capital, autoimmune disease, Eli Lilly, AnaptysBio, Medicxi, OrbiMed
Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity
Stat
Mon, 06/13/22 - 09:49 pm
Tags:
Eli Lilly, FDA, alopecia areata, olumiant
State high court says Eli Lilly warned doctor of drug risks, didn’t need to warn patient
MedCity News
Fri, 06/10/22 - 10:33 am
Tags:
Eli Lilly, physicians, Cialis, legal
Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data
Fierce Biotech
Wed, 06/8/22 - 10:34 am
Tags:
Innovent, Eli Lilly, Novo Nordisk, obesity, clinical trials, mazdutide
ADA: Eli Lilly's stellar tirzepatide weight loss data tee up showdown with Novo Nordisk's Wegovy, analysts say
Fierce Pharma
Mon, 06/6/22 - 11:42 pm
Tags:
Eli Lilly, Mounjaro, tirzepatidem diabetes, weight loss
State supreme court rules in favor of Eli Lilly in case over warning patients of risks when DTC ads are in play
Endpoints
Sun, 06/5/22 - 11:37 pm
Tags:
Eli Lilly, Washington, patients

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.